Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-23-024880

Options or other derivatives

  • Chief Commercial Officer acquired 192,143 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Evanson Jeff · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +192,143 192,143 D
Loading xslF345X04/doc4.xml…